✦ LIBER ✦

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII

✍ Scribed by Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; Elena Santagostino; Piermannuccio Mannucci; the ReFacto–AICE Study Group

Book ID: 108672742
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 130 KB
Volume: 126
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2004.05058.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and inhibitor development in pr

Efficacy and inhibitor development in previously treated patients with haemophilia A switched to a B domain-deleted recombinant factor VIII – clarification of Kogenate inhibitor data

✍ Peter Larson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The safety and efficacy of B-domain dele

The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update

✍ J. M. Lusher; D. A. Roth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

Continuous infusion of B-domain deleted

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience

✍ N. Stieltjes; C. Altisent; G. Auerswald; C. Négrier; P. Pouzol; J. Reynaud; V. R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Safety and efficacy of a sucrose-formula

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

✍ J. SHI; Y. ZHAO; J. WU; J. SUN; L. WANG; R. YANG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Cumulative analysis of inhibitor formati

Cumulative analysis of inhibitor formation in patients with haemophilia A treated with sucrose-formulated recombinant factor VIII

✍ N. BAJWA; M. M. ENRIQUEZ; E. GORINA; G. LEMM 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Rate of inhibitor development in previou

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review

✍ A. IORIO; S. HALIMEH; S. HOLZHAUER; N. GOLDENBERG; E. MARCHESINI; M. MARCUCCI; G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB